Synthesis of bioactive quinoline acting as anticancer agents and their mode of action using in silico analysis towards Aurora kinase A inhibitors

[1]  P. Lobie,et al.  Novel Biphenyl Amines Inhibit Oestrogen Receptor (ER)-α in ER-Positive Mammary Carcinoma Cells , 2021, Molecules.

[2]  G. Sethi,et al.  Brusatol suppresses STAT3-driven metastasis by downregulating epithelial-mesenchymal transition in hepatocellular carcinoma , 2020, Journal of advanced research.

[3]  G. Sethi,et al.  Vitexin abrogates invasion and survival of hepatocellular carcinoma cells through targeting STAT3 signaling pathway. , 2020, Biochimie.

[4]  M. Abdelgawad,et al.  Sulfonamide-based 4-anilinoquinoline derivatives as novel dual Aurora kinase (AURKA/B) inhibitors: Synthesis, biological evaluation and in silico insights. , 2020, Bioorganic & medicinal chemistry.

[5]  Basappa,et al.  Identification of a novel 1,2 oxazine that can induce apoptosis by targeting NF-κB in hepatocellular carcinoma cells , 2020, Biotechnology reports.

[6]  Chandra,et al.  Synthesis of Piperidine Conjugated Dihydroquinazolin-4(1H)-ones and their Antiproliferative Activity, Molecular Docking Studies and DFT Calculations , 2019 .

[7]  K. H. Narasimhamurthy,et al.  A modified approach for the site-selective direct C-6 arylation of benzylated uracil , 2019 .

[8]  R. Cao,et al.  Design, synthesis and biological evaluation of new quinoline derivatives as potential antitumor agents. , 2019, European journal of medicinal chemistry.

[9]  Tianyu Zhang,et al.  Quinoline Derivatives Kill Mycobacterium tuberculosis by Activating Glutamate Kinase. , 2019, Cell chemical biology.

[10]  G. Sridhar,et al.  Synthesis and biological evaluation of chalcone fused quinoline derivatives as anticancer agents , 2019, Chemical Data Collections.

[11]  Salman A. Khan,et al.  Synthesis and evaluation of Quinoline-3-carbonitrile derivatives as potential antibacterial agents. , 2019, Bioorganic chemistry.

[12]  A. Goutopoulos,et al.  Synthesis and SAR development of quinoline analogs as novel P2X7 receptor antagonists. , 2019, Bioorganic & medicinal chemistry letters.

[13]  K. Rangappa,et al.  Utility of ZrO2–Al2O3 in the synthesis of 2,3-dihydroquinazolin-4(1H)-ones , 2019, Chemical Data Collections.

[14]  J. Sévigny,et al.  Investigation of new quinoline derivatives as promising inhibitors of NTPDases: Synthesis, SAR analysis and molecular docking studies. , 2019, Bioorganic chemistry.

[15]  Basappa,et al.  Targeting Heparanase in Cancer: Inhibition by Synthetic, Chemically Modified, and Natural Compounds , 2019, iScience.

[16]  Y. Pérez-Pertejo,et al.  Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents. , 2019, European journal of medicinal chemistry.

[17]  Zhi Xu,et al.  Quinoline hybrids and their antiplasmodial and antimalarial activities. , 2017, European journal of medicinal chemistry.

[18]  C. Prigent,et al.  Aurora A Kinase Is a Priority Pharmaceutical Target for the Treatment of Cancers. , 2017, Trends in pharmacological sciences.

[19]  S. Rangappa,et al.  An azaspirane derivative suppresses growth and induces apoptosis of ER-positive and ER-negative breast cancer cells through the modulation of JAK2/STAT3 signaling pathway. , 2016, International journal of oncology.

[20]  K. Rangappa,et al.  Synthesis and antiproliferative efficiency of novel bis(imidazol-1-yl)vinyl-1,2,4-oxadiazoles , 2016 .

[21]  E. Sajo,et al.  The radiosensitizing effect of the aurora kinase inhibitors, ENMD-2076, on canine mast cell tumours in vitro. , 2016, Veterinary and comparative oncology.

[22]  J. Lunceford,et al.  A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors , 2016, Investigational New Drugs.

[23]  A. Desai,et al.  A Cell Biologist’s Field Guide to Aurora Kinase Inhibitors , 2015, Front. Oncol..

[24]  Basappa,et al.  Synthesis, biological evaluation and in silico and in vitro mode-of-action analysis of novel dihydropyrimidones targeting PPAR-γ , 2014 .

[25]  K. Rangappa,et al.  Synthesis and antiproliferative effect of novel 4-thiazolidinone-, pyridine- and piperazine-based conjugates on human leukemic cells. , 2014, European journal of medicinal chemistry.

[26]  T. R. Swaroop,et al.  Synthetic utility of propylphosphonic anhydride-DMSO media. An efficient one-pot three-component synthesis of 2-arylquinolines. , 2013 .

[27]  H. Hsieh,et al.  Identification, SAR Studies, and X‐ray Co‐crystallographic Analysis of a Novel Furanopyrimidine Aurora Kinase A Inhibitor , 2010, ChemMedChem.

[28]  W. Hopfenmüller,et al.  ZM447439, a Novel Promising Aurora Kinase Inhibitor, Provokes Antiproliferative and Proapoptotic Effects Alone and in Combination with Bio- and Chemotherapeutic Agents in Gastroenteropancreatic Neuroendocrine Tumor Cell Lines , 2009, Neuroendocrinology.

[29]  A. Chakravarty,et al.  MLN8054, a Small-Molecule Inhibitor of Aurora A, Causes Spindle Pole and Chromosome Congression Defects Leading to Aneuploidy , 2007, Molecular and Cellular Biology.